Search the Site


test tubes

$ASTX Cancer Biotech Trading Near Cash with Pending FDA (sNDA) Decision

publication date: Jan 10, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Written by Mike Havrilla--Astex Pharma (NASDAQ:ASTX) is a cancer biotech w/ an approved drug that is marketed by Japan-based Eisai along with a summary of the Company's pending FDA and clinical trial catalysts below.

Sorry this page is available to subscribers only. 

You can also sign up for our 100% FREE Newsletter  to stay current on public webinars, special offers, and news alerts:


If you are already a subscriber, please login.

To gain access to the members only content click here to subscribe.

If you believe you should be able to view this area then please contact us and we will try to rectify this issue as soon as possible.